Catalogue Search | MBRL
Search Results Heading
Explore the vast range of titles available.
MBRLSearchResults
-
DisciplineDiscipline
-
Is Peer ReviewedIs Peer Reviewed
-
Reading LevelReading Level
-
Content TypeContent Type
-
YearFrom:-To:
-
More FiltersMore FiltersItem TypeIs Full-Text AvailableSubjectCountry Of PublicationPublisherSourceTarget AudienceDonorLanguagePlace of PublicationContributorsLocation
Done
Filters
Reset
6
result(s) for
"Etching, Spanish"
Sort by:
Moors and the Bullfight: History and National Identity in Goya's Tauromaquia
2008
Francisco Goya's representation of the history of the bullfight in the Tauromaquia series (1815-16) provides important insights into national identity formation in early-nineteenth-century Spain. These prints give the Muslims of al-Andalus an unprecedented (and historically unfounded) role in the evolution of this quintessentially Spanish pastime. By equating national belonging with the development of cultural practices that transcend religious difference, the Tauromaquia absorbs the Islamic past into the fabric of Spanish history. In doing so it marks a significant departure from the ideology of Christian Reconquest, which took on renewed significance following the Peninsular War with Napoleonic France (1808-13).
Journal Article
RealPennies: Alerts: Turning Pennies into Dollars (OTC: HLUN), (NASDAQ: AMGN), (NYSE: DNA), (NASDAQ: CELG)
2007
M2 PRESSWIRE-March 23, 2007-RealPennies: Alerts: Turning Pennies into Dollars (OTC: HLUN), (NASDAQ: AMGN), (NYSE: DNA), (NASDAQ: CELG) (C)1994-2007 M2 COMMUNICATIONS LTD RealPennies.com ALERTS: reporting on dollar volume movers: Healtheuniverse, Inc. (OTC: HLUN), Amgen Inc. (NASDAQ: AMGN), Genentech Inc. (NYSE: DNA), Celgene Corp. (NASDAQ: CELG) Amgen Inc. (NASDAQ: AMGN) on Thursday said that it pulled its Vectibix treatment from clinical trials after tests showed that combination use of the drug with Avastin in patients with metastatic colon cancer worsened the progression of the disease. Amgen canceled the trial after the first 231 incidences of disease progression or patient death. Amgen was testing the addition of Vectibix in combination with chemotherapy and Genentech Inc.'s Avastin. The drug is already approved solely to treat colon cancer in combination with chemotherapy.
Newsletter